Summary
Evecxia Inc.
Founded in 2013
Description
Evecxia Therapeutics is dedicated to realizing the therapeutic potential of 5-hydroxytryptophan (5-HTP) for the treatment of mental illness.
Strengths
- Evecxia Inc. has a strong market share in their industry
- Revenue generated per employee is greater than industry average
- Demonstrating revenue growth that is faster than the industry average
- The number of employees is growing faster than the industry average
- Revenue growth is more steady than the industry average
- Since Evecxia Inc. was founded, the company has grown faster than the industry average
Annual Revenue
Evecxia Inc.'s annual revenue
$1264000
Based on Kona Equity data
-
Revenue per employee
$210667
-
Variance of revenue growth
0.29
-
Annual revenue growth since founding
$129444
-
Revenue growth rate from first known quarter to current
-74.7%
Employee Count
6 employees
-
Employee growth rate from first known quarter to current
-73.9%
Executives
John Kaiser
Chief Executive Officer and Chairman of Directors
j**@evecxia.comJacob Jacobsen
Chief Scientific Officer
j**@evecxia.comJoseph Patti
CEO
j**@evecxia.comRebecca Klein
Director, Pharmacology& Project Management
r**@evecxia.comBrian Fillenwarth
Accountant
b**@evecxia.comJennifer Hart
Executive Director, Operations
j**@evecxia.comPhone Evecxia
President & Chief Executive Officer
p**@evecxia.comG Score - 6
The G Score is an eight-point scale where firms are given a score of 1 for each of the criteria that they pass. The G score compares a company against the industry median to find those that are healthy and growing.
- G1 Revenue is greater than the industry median.
- G2 Income per employee more than industry average.
- G3 Revenue growth rate from the first known quarter to current is higher than the industry average.
- G4 Employee growth rate from the first known quarter to current is higher than the industry average.
- G5 Variance of revenue growth is less than the industry average
- G6 Annual revenue growth since founding is higher than the industry average.
Location
Unlock unlimited leads
Similar Companies
Leverage Pharma
leveragepharma.com- Annual Revenue: $1.1M
- Employees: 3
- Leverage Pharma is a development stage specialty pharmaceutical company created by a management team of pharmaceutical industry executives with significant experience with large pharmaceutical companies. Leverage Pharma is focused on modified drug delivery prescription products. Of special interest are orally disinteg…
- Founded in 2006
- Annual Revenue: $4.2M
- Employees: 32
SHINKEI Therapeutics
shinkeitherapeutics.com- Founded in 2017
- Location: Princeton, NJ
- Annual Revenue: $885.0K
- Employees: 5
- SHINKEI Therapeutics is a clinical stage pharmaceutical company focused on Central Nervous System (CNS) disorders. They use the 505(b)2 regulatory strategy to repurpose existing pharmaceutical products for faster and better patient outcomes. Their prod...
Vyteris
vyteris.com- Founded in 2000
- Location: Fair Lawn, NJ
- Annual Revenue: $6.8M
- Employees: 32
- Vyteris is a leading provider of innovative transdermal drug delivery solutions. Our proprietary Smart Patch technology enables the efficient and precise delivery of medications through the skin, offering patients a convenient and painless alternative ...
Chase Theraputics
chasetherapeutics.com- Founded in 2017
- Location: Washington, DC
- Annual Revenue: $3.9M
- Employees: 8
- Chase Therapeutics is an early-stage, product-based specialty pharmaceutical company focused on the development of better treatments for brain disease.
Promentis Pharmaceuticals Inc
promentispharma.com- Founded in 2007
- Location: Milwaukee, WI
- Annual Revenue: $10.0M
- Employees: 5
- Promentis Pharmaceuticals is a privately held biopharmaceutical company based in Milwaukee, WI. They specialize in developing antipsychotic drugs to treat schizophrenia and other neuropsychiatric disorders. Their drug development program focuses on act...
Key Information
- Name: Evecxia Inc.
- SIC: 80; 283
- NAICS: 3254; 32
See similar companies
-
By City Durham
-
By State NC Small companies in NC
-
Firmographic data G Score of 6 Founded in 2013 SIC: 80 SIC: 283 NAICS: 3254 NAICS: 32 #Biotechnology #Pharmaceuticals #Healthcare
Frequently Asked Questions
Evecxia Inc.'s headquarters are located at 2 Davis Dr. Durham, NC 27709.
Evecxia Inc.'s official website is evecxia.com
Evecxia Inc.'s annual revenue is $1.3 M.
Evecxia Inc.'s SIC: 80; 283
Evecxia Inc.'s NAICS: 3254; 32.
Evecxia Inc. has 6 employees
